Problems of Social Hygiene, Public Health and History of MedicineProblems of Social Hygiene, Public Health and History of Medicine0869-866X2412-2106Joint-Stock Company Chicot156010.32687/0869-866X-2024-32-6-1249-1253НеопределенThe oncological screening of diseases of gynecological and urological profile as one of measures preventing reproductive health: A reviewLuzanovO Aquicksilvernov789@gmail.comOlkhovIlya Gennadievichinfo@bfrazvitie.ruGrishinaN Knot@provid.edObakovaS Rsabinam10@yandex.ruN. A. Semashko National Research Institute of Public Health, 105064, Moscow, Russia091220243262704202527042025Copyright © 2025,2025<p>The article describes complex of organizational legal aspects of oncological screening for gynecological and urological diseases. These types of screening can be considered as preventive measure not only preventing development of malignant tumors of genitourinary system, but preserving male and female reproductive health, since protection of reproductive health is also preservation of public health of population.</p>oncological screeningcervical cancerprostate cancerprimary health carepublications reviewонкоскрининграк шейки маткирак предстательной железыпервичная медико-санитарная помощьобзор литературы1.Maksimova Zh. V., Maksimov D. M. Screening: a modern view on early diagnosis and prevention of chronic non-communicable diseases. Archive of Internal Medicine. 2014;6(20):52–6 (in Russian).2.Nechaeva O. B. Assessment of medical care for oncology diseases in Russia. Current Problems of Health Care and Medical Statistics. 2020;(1):246–66 (in Russian).3.Senenko A. Sh., Son I. M., Dzyuba N. A., Zakharchenko O. O., Terent’yeva D. S., Shelgunov V. A. Lean manufacturing technologies in reforming medical organizations that provide primary health care. Analytical review. Social Aspects of Population Health. 2020;66(4):6. doi: 10.21045/2071-5021-2020-66-4-6 (in Russian).4.Komanenko A. A., Avdeeva M. V., Garifullin T. Yu., Filatov V. N. Directions and methods for improving performance of district therapist in implementing “New model of medical organization providing primary health care” project. Social Aspects of Population Health. 2020;66(4):5. doi: 10.21045/2071-5021-2020-66-4-5 (in Russian).5.Shmakova N. A., Chistyakova G. N., Kononova I. N., Remizova I. I. Features of genotyping of human papillomavirus infection in patients with cervical intraepithelial neoplasia. Ulyanovsk Medical and Biological Journal. 2020;(3):104–11 (in Russian).6.Wright T., Zhang G., Behrens C. M. Screening with Prejudice; how knowledge of patients HPV status impacts the performance of cervical cytology in the ATHENA trial. In: Abstracts 15 Wold Congress for Cervical Pathology and Colposcopy. 2014. P. 56–7.7.Pushkar D. Yu., Govorov A. V., Sidorenkov A. V., Prilepskaya E. A., Kovylina M. V. Early diagnosis of prostate cancer. Methodological recommendations No.19 of the Moscow Department of Health. Moscow; 2015. 51 p. (in Russian).8.Boytsov S. A., Ipatov P. V., Kalinina A. M., et al. Organization of medical examination of certain groups of the adult population. Moscow; 2015. 134 p. (in Russian).9.Aksenov V. A. Commentary on the article by O. Yu. Rebrova et al. “Screenings of the first stage of clinical examination: a systematic review of long-term effectiveness.” Pharmacoeconomics. Modern Pharmacoeconomics and Pharmacoepidemiology. 2018;11(2):77–80. doi: 10.17749/2070-4909.2018.11.2.077-080 (in Russian).10.Marth C., Landoni F., Mahner S. On behalf of the ESMO Guidelines Committee; Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2017;28(4-1):72–83. doi: 10.1093/annonc/ mdx22011.Komanenko A. A., Avdeeva M. V., Garifullin T. Yu., Filatov V. N. Application of lean technologies to optimize cancer screening during clinical examination of certain groups of the adult population. Acta biomedica scientifica. 2021;6(6-2):145–53. doi: 10.29413/ABS.2021-6.6-2.15 (in Russian).12.Dombrovsky V. S., Khachatryan G. R. Comparison of recommended screening programs in the USA, Canada, the Netherlands and Germany. Pharmacoeconomics. Modern Pharmacoeconomics and Pharmacoepidemiology. 2016;(4):46-53 (in Russian).13.Pan Q. J., Hu S. Y., Zhang X. Pooled Analysis of Performance of Liquid Based Cytology in Population-Based Cervical Cancer Screening Studies in China. Cancer Cytopathol. 2013;121(9):473–82. doi: 10,1002/cncy.2129714.Minkina G. N. Cytological screening for cervical cancer: from the traditional PAP test to computer technology. Obstetrics, Gynecology and Reproduction. 2017;11(1):56–63. doi:10.17749/2313-7347.2017.11.1.056-063 (in Russian).15.Komarova L. E. Current state of screening programs in oncology. Russian Journal of Oncology. 2013;(5):48–51 (in Russian).16.Collin S. M., Martin R. M., Metcalfe C. Prostate-cancer mortality in the USA and UK in 1975—2004: an ecological study. Lancet Oncol. 2008;9(5):445—52.17.Zaridze D. G. Cancer prevention, a guide for doctors. Moscow: LLC “IMN-Press”; 2009 (in Russian).18.Olkov I. G., Grishina N. K. Preferred strategies for cervical virological screening programs (publications review). Problems of Social Hygiene, Health Care and History of Medicine. 2023;31(2):233–41. doi: 10.32687/0869-866X-2023-31-2-233-241 (in Russian).19.Pogosova N. V., Yufereva Yu. M., Samorodskaya I. V., Boytsov S. A. Preventive screening: all the pros and cons. Cardiovascular Therapy and Prevention. 2016;15(3):4–13 (in Russian).20.Mazitova M. I., Bikineev M. S. Stages of development of cytological screening for cervical cancer. RMJ. Mother and Child. 2019;2(4):322–6 (in Russian).